Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Akumin Inc. operates a network of outpatient imaging centers across the United States, specializing in diagnostic imaging services such as MRI, CT scans, and PET scans. The company differentiates itself through strategic partnerships with healthcare providers and a focus on patient-centric care, which drives patient volume and revenue growth.
Akumin generates revenue primarily through the provision of diagnostic imaging services to patients referred by healthcare providers. The company benefits from a growing demand for outpatient imaging services, driven by an aging population and increased prevalence of chronic diseases. Its competitive advantages include a robust network of locations, strategic partnerships, and a focus on high-quality patient care.
Volume of diagnostic imaging procedures performed
Partnership agreements with healthcare providers
Regulatory changes affecting reimbursement rates
Technological advancements in imaging equipment
Regulatory changes impacting reimbursement rates for imaging services
Technological disruption from advancements in imaging technology
Increased competition from other outpatient imaging centers and hospitals
Potential market entry by larger healthcare systems
Negative net margins leading to potential liquidity issues
Dependence on external financing for growth initiatives
moderate - As a healthcare provider, Akumin's services are somewhat insulated from economic downturns, but discretionary spending on healthcare can be affected by economic conditions.
Higher interest rates could increase financing costs for Akumin's capital expenditures, impacting profitability and expansion plans.
minimal - The company has a negative debt/equity ratio, indicating low reliance on external financing.
growth - Investors may be drawn to Akumin's rapid revenue growth and expansion potential in the outpatient imaging market.
high - The stock has exhibited significant price volatility, with a 1-year return of -67.9%.
